Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis

Journal of Neuroimmunology

Volumn 221, Issue 1-2, 2010, Pages 95-100

  Hirotani, Makoto ^a   Niino, Masaaki ^a   Fukazawa, Toshiyuki ^b   Kikuchi, Seiji ^c   Yabe, Ichiro ^a   Hamada, Shinsuke ^d   Tajima, Yasutaka ^e   Sasaki, Hidenao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Neurology Clinic   (Japan)

^c HOKKAIDO MEDICAL CENTER   (Japan)

^d Hokuyukai Neurology Hospital   (Japan)

^e SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

CpG DNA; Immunoregulation; MS; TLR9

Indexed keywords

BETA1A INTERFERON; CYTOKINE; INTERFERON BETA SERINE; INTERLEUKIN 10; TOLL LIKE RECEPTOR 9; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; LEUKOCYTE ANTIGEN; OLIGODEOXYRIBONUCLEOTIDE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOREGULATION; MALE; MEMORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTOR 9;

EID: 77951244580     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.02.012     Document Type: Article

References (19)

1. Bach J.F. The effect of infections on susceptibility to autoimmune encephalomyelitis. N. Engl. J. Med. 2002, 347:911-920.
2. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naïve B cells and constitutive expression in memory B cells. Blood 2003, 101:4500-4504.
3. Boonstra A., Rajsbaum R., Holman M., Marques R., Asselin-Paturel C., Pereira J.P., Bates E.E., Akira S., Vieira P., Liu Y.J., Trinchieri G., O'Garra A. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 2006, 177:7551-7558.
4. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., Bar-Or A. Distinct effector cytokine profiles of memory and naïve human B cell subsets and implication in multiple sclerosis. J. Immunol. 2007, 178:6092-6099.
5. Fillatreau S., Sweenie C., McGeacht M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
6. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune response. Nat. Immunol. 2004, 5:987-995.
7. Lampropoulou V., Hoehlig K., Roch T., Neves P., Gomez E.C., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., Fillatreau S. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008, 180:1763-1773.
8. Lehmann D., Ben-Nun A. Bacterial agents protect against autoimmune disease: I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J. Autoimmun. 2002, 5:675-690.
9. Marta M., Andersson A., Isaksson M., Kampe O., Lobell A. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2008, 38:565-575.
10. McGeachy M.J., Bak-Jansen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
11. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Touetellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
12. Prinz M., Garbe F., Schmidt H., Mildner A., Gutcher I., Wolter K., Piesche M., Schroers R., Weiss E., Kirschning C.J., Rochford C.D., Bruck W., Becher B. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 2006, 203:456-464.
13. Randomized double-blind placebo-controlled study of interferonβ-1a in relapsing/remitting multiple sclerosis. Lancet 1998, 352:1498-1504. PRISMS (Prevention of Relapses and Disability by Interferon-β-1a Subcutaneously in Multiple Sclerosis) Study Group.
14. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:424-432.
15. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993, 43:655-661. The IFN-β Multiple Sclerosis Study Group.
16. Vos Q., Lees A., Wu Z.Q., Snapper C.M., Mond J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 2000, 176:154-170.
17. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in B cell-deficient mice. J. Exp. Med. 1996, 184:2271-2278.
18. Zhang X., Tang Y., Sujkowska D., Wang D., Ramgolam V., Sospedra M., Adams J., Martin R., Pinilla C., Markovic-Plese S. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis. Eur. J. Immunol. 2008, 38:1297-1309.
19. Zhang X., Jin J., Tang Y., Speer D., Sujkowska D., Markovic-Plese S. IFNβ-1a inhibits the secretion of TH17-polarizing cytokines in human dendritic cells via TLR8 up-regulation. J. Immunol. 2009, 182:3928-3936.